(OCSL) Oaktree Specialty Lending - Ratings and Ratios
Debt, Financing, Loans, Equity, Secured
OCSL EPS (Earnings per Share)
OCSL Revenue
Description: OCSL Oaktree Specialty Lending
Oaktree Specialty Lending Corporation is a business development company that provides financing solutions to middle-market companies, focusing on investments in debt financing, including first and second lien debt, unsecured and mezzanine loans, and equity co-investments. Its investment strategy targets small and mid-sized companies across various industries, including education services, healthcare, manufacturing, and technology.
The companys investment portfolio is diversified across multiple sectors, with a focus on companies with enterprise values between $20 million and $150 million and EBITDA between $3 million and $50 million. Oaktree Specialty Lending Corporation typically invests between $5 million to $75 million per transaction, often taking on a lead investor role in its portfolio companies.
With a strong presence in North America, the company has a proven track record of providing financing solutions to companies in various stages of growth, including expansions, sponsor-led acquisitions, and management buyouts. Its investment approach is characterized by a flexible and adaptable strategy, allowing it to respond to changing market conditions and capitalize on emerging opportunities.
From a technical analysis perspective, OCSLs stock price has been trending near its 50-day moving average, indicating a relatively stable short-term outlook. The stocks 14.48 200-day moving average suggests a longer-term downtrend, potentially presenting a buying opportunity for investors. With an ATR of 0.27, representing a 1.95% daily price range, the stocks volatility is relatively moderate.
Combining technical and fundamental data, a forecast for OCSL can be derived. Given the companys P/E Forward ratio of 9.03, indicating a relatively attractive valuation, and its diversified investment portfolio, a potential price target for OCSL could be around $15.50, representing a 13.5% increase from the current price. This forecast is based on the assumption that the companys investment performance will continue to drive earnings growth, ultimately reflected in its stock price. However, its essential to monitor the companys RoE of 0.61, which, although low, may be influenced by the current market conditions and the companys investment strategy.
OCSL Stock Overview
| Market Cap in USD | 1,180m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2008-06-12 |
OCSL Stock Ratings
| Growth Rating | 28.6 |
| Fundamental | 63.9% |
| Dividend Rating | 89.7 |
| Rel. Strength | -24.0 |
| Analysts | 3.33 of 5 |
| Fair Price Momentum | 14.54 USD |
| Fair Price DCF | 45.74 USD |
OCSL Dividends
| Dividend Yield 12m | 14.22% |
| Yield on Cost 5y | 22.49% |
| Annual Growth 5y | 12.61% |
| Payout Consistency | 91.1% |
| Payout Ratio | 101.0% |
OCSL Growth Ratios
| Growth Correlation 3m | 2.1% |
| Growth Correlation 12m | -54.5% |
| Growth Correlation 5y | 59.9% |
| CAGR 5y | 8.75% |
| CAGR/Max DD 5y | 0.29 |
| Sharpe Ratio 12m | 0.65 |
| Alpha | -19.97 |
| Beta | 0.654 |
| Volatility | 22.15% |
| Current Volume | 618.6k |
| Average Volume 20d | 651.4k |
| Stop Loss | 13 (-3.4%) |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (46.3m TTM) > 0 and > 6% of Revenue (6% = 9.12m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 1.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.66% (prev 51.88%; Δ -20.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 322.5m > Net Income 46.3m (YES >=105%, WARN >=100%) |
| Net Debt (-79.8m) to EBITDA (33.5m) ratio: -2.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (88.1m) change vs 12m ago 7.65% (target <= -2.0% for YES) |
| Gross Margin 34.92% (prev 96.47%; Δ -61.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.84% (prev 5.23%; Δ -0.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.59 (EBITDA TTM 33.5m / Interest Expense TTM 121.9m) >= 6 (WARN >= 3) |
Altman Z'' -1.92
| (A) 0.02 = (Total Current Assets 103.1m - Total Current Liabilities 55.0m) / Total Assets 2.96b |
| (B) -0.30 = Retained Earnings (Balance) -891.7m / Total Assets 2.96b |
| (C) -0.06 = EBIT TTM -193.2m / Avg Total Assets 3.14b |
| (D) -0.60 = Book Value of Equity -890.9m / Total Liabilities 1.49b |
| Total Rating: -1.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.94
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 27.91% = 5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.04 = 2.50 |
| 5. Debt/Ebitda 1.65 = 0.68 |
| 6. ROIC - WACC data missing |
| 7. RoE 3.14% = 0.26 |
| 8. Revenue Trend data missing |
| 9. Rev. CAGR 53.56% = 2.50 |
| 10. EPS Trend data missing |
| 11. EPS CAGR 26.26% = 2.50 |
As of August 13, 2025, the stock is trading at USD 13.46 with a total of 618,620 shares traded.
Over the past week, the price has changed by -0.37%, over one month by -6.59%, over three months by -1.10% and over the past year by -5.21%.
Neither. Based on ValueRay´s Fundamental Analyses, Oaktree Specialty Lending is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 63.94 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OCSL is around 14.54 USD . This means that OCSL is currently overvalued and has a potential downside of 8.02%.
Oaktree Specialty Lending has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold OCSL.
- Strong Buy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, OCSL Oaktree Specialty Lending will be worth about 16.2 in August 2026. The stock is currently trading at 13.46. This means that the stock has a potential upside of +20.28%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.6 | 1% |
| Analysts Target Price | 14.1 | 4.6% |
| ValueRay Target Price | 16.2 | 20.3% |
OCSL Fundamental Data Overview
CCE Cash And Equivalents = 79.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 23.5088
P/E Forward = 8.8028
P/S = 3.3356
P/B = 0.7929
P/EG = 0.9343
Beta = 0.749
Revenue TTM = 152.0m USD
EBIT TTM = -193.2m USD
EBITDA TTM = 33.5m USD
Long Term Debt = 269.0k USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 55.0m USD (from totalCurrentLiabilities, last fiscal year)
Debt = 55.3m USD (Calculated: Short Term 55.0m + Long Term 269.0k)
Net Debt = -79.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.16b USD (1.18b + Debt 55.3m - CCE 79.8m)
Interest Coverage Ratio = -1.59 (Ebit TTM -193.2m / Interest Expense TTM 121.9m)
FCF Yield = 27.91% (FCF TTM 322.5m / Enterprise Value 1.16b)
[93m FCF Margin = 212.2% (FCF TTM 322.5m / Revenue TTM 152.0m)
[39m Net Margin = 30.42% (Net Income TTM 46.3m / Revenue TTM 152.0m)
Gross Margin = 34.92% ((Revenue TTM 152.0m - Cost of Revenue TTM 98.9m) / Revenue TTM)
[93m Tobins Q-Ratio = -1.30 (set to none) (Enterprise Value 1.16b / Book Value Of Equity -890.9m)
[39m[93m Interest Expense / Debt = 56.21% (Interest Expense 31.1m / Debt 55.3m)
[39m[93m Taxrate = -0.19% (set to none) (from yearly Income Tax Expense: -108.0k / 57.8m)
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m Current Ratio = 1.88 (Total Current Assets 103.1m / Total Current Liabilities 55.0m)
Debt / Equity = 0.04 (Debt 55.3m / last Quarter total Stockholder Equity 1.48b)
Debt / EBITDA = 1.65 (Net Debt -79.8m / EBITDA 33.5m)
Debt / FCF = 0.17 (Debt 55.3m / FCF TTM 322.5m)
Total Stockholder Equity = 1.47b (last 4 quarters mean)
RoA = 1.56% (Net Income 46.3m, Total Assets 2.96b )
RoE = 3.14% (Net Income TTM 46.3m / Total Stockholder Equity 1.47b)
RoCE = -13.12% (Ebit -193.2m / (Equity 1.47b + L.T.Debt 269.0k))
[93m RoIC = unknown (NOPAT none, Invested Capital 3.00b, Ebit -193.2m)
[39m[93m WACC = unknown (E(1.18b)/V(1.24b) * Re(8.42%)) + (D(55.3m)/V(1.24b) * Rd(none%) * (1-Tc(none)))
[39m Shares Correlation 5-Years: 100.0 | Cagr: 11.22%
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.62% ; FCFE base≈324.3m ; Y1≈288.5m ; Y5≈241.6m
Fair Price DCF = 45.74 (DCF Value 4.03b / Shares Outstanding 88.1m; 5y FCF grow -13.62% → 2.90% )
Revenue Correlation: N/A | Revenue CAGR: 53.56%
Revenue Growth Correlation: -21.24%
EPS Correlation: N/A | EPS CAGR: 26.26%
EPS Growth Correlation: 47.07%
Additional Sources for OCSL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle